One Manufacturing Change, Ten Countries, Ten Reviews? EMA Is Testing Another Way
EMA published new practical guidance on August 13, 2026 explaining how pharmaceutical companies can participate in pilots where national authorities rely fully or partially on EMA’s assessment of post-authorisation changes. The potential prize is substantial: fewer duplicated technical reviews and faster global implementation of approved changes. But reliance does not…